ReviewDrug design, development and therapy2022

Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in Therapy.

Chaudry Nasir Majeed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.